One of the key advantages of MammaPrint is that it helps to avoid overtreatment. By identifying patients who are at low risk of recurrence, it enables doctors to recommend less aggressive treatments, such as avoiding chemotherapy, which can have significant side effects. Conversely, it also identifies high-risk patients who might benefit from more intensive treatment strategies.